Teva Pharmaceutical Industries Ltd ADR buy StockNews.com
Start price
03.08.24
/
50%
€14.80
Target price
03.08.25
-
Performance (%)
-9.80%
End price
04.08.25
€13.35
Summary
This prediction ended on 04.08.25 with a price of €13.35. With a performance of -9.80%, the BUY prediction by StockNews_com finished with a loss. StockNews_com has a follow-up prediction for Teva Pharmaceutical Industries Ltd ADR where he still thinks Teva Pharmaceutical Industries Ltd ADR is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Teva Pharmaceutical Industries Ltd ADR | 3.673% | 3.673% | 57.764% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by StockNews_com for this prediction
In the thread Teva Pharmaceutical Industries Ltd ADR diskutieren
Teva Pharmaceutical Industries Limited (NYSE: TEVA) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for TEVA provided by MarketBeat
In the thread Trading Teva Pharmaceutical Industries Ltd ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Teva Pharmaceutical Industries Ltd ADR
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€13.00
04.04.25
04.04.25
-
04.04.26
04.04.26
95.38%
12.12.25
12.12.25
